This compound is a pharmaceutical intermediate used in the manufacturing of dapagliflozin, a medication for type 2 diabetes, heart failure, and chronic kidney disease. It functions as a key building block in the synthesis of this SGLT-2 inhibitor.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 461432-24-6
(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
pharmaceutical intermediate for dapagliflozin
4-Oxo-4-(p-tolyl)butanoic acid
Pharmaceutical intermediate for impurities
FLUOROBENZENE
Pharmaceutical intermediate
3-AMINOPYRIDINE
Pharmaceutical and agrochemical intermediate
(2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
Pharmaceutical intermediate for dapagliflozin analogs
(2S,3R,4S,5S)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,6-bis(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
Pharmaceutical intermediate
(3R,4S,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol
GKTWLVVOULBRDU-VEIQOZLZSA-N
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3([C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)OC)Cl
—